U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company’s president in the country…
Read More: https://www.fool.com/investing/2024/12/22/is-astrazeneca-stock-a-buy/?source=iedfolrf0000001
